Blog
Planify news
Medikabazaar Slips Into Red, Posts INR 20.8 Cr Loss In FY22
Link copied
Medikabazaar Slips Into Red, Posts INR 20.8 Cr Loss In FY22
28 March 2023
Mumbai-based B2B healthcare supply chain startup Medikabazaar slipped into the red in the financial year ending March 31, 2023. The CDC-backed soonicorn startup reported a net loss of INR 20.8 Cr in the financial year 2021-22 (FY22) as against a net profit of INR 61 Lakh in FY21. Though the startup reported a loss in FY22, revenue from operations jumped over 3X or 175% to INR 1,552.5 Cr from INR 564.7 Cr in FY21.
Mumbai-based B2B healthcare supply chain startup Medikabazaar slipped into the red in the financial year ending March 31, 2023. The CDC-backed soonicorn startup reported a net loss of INR 20.8 Cr in the financial year 2021-22 (FY22) as against a net profit of INR 61 Lakh in FY21. Though the startup reported a loss in FY22, revenue from operations jumped over 3X or 175% to INR 1,552.5 Cr from INR 564.7 Cr in FY21.
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.